These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7582937)

  • 1. Lithium and anti-viral drug toxicity: II. Further studies on the ability of lithium to modulate the hematopoietic toxicity associated with the anti-viral drug zidovudine (AZT).
    Kazim S; Townsley L; Hughes NK; Tse KF; Ling J; Scott K; Birch NJ; Gallicchio VS
    Rom J Physiol; 1993; 30(3-4):231-9. PubMed ID: 7582937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
    Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
    Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the haematopoietic toxicity associated with zidovudine in vivo with lithium carbonate.
    Gallicchio VS; Hughes NK; Tse KF
    J Intern Med; 1993 Mar; 233(3):259-68. PubMed ID: 8450294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium and hematopoietic toxicity. II. Acceleration in vivo of murine hematopoietic progenitor cells (CFU-gm and CFU-meg) following treatment with vinblastine sulfate.
    Gallicchio VS
    Int J Cell Cloning; 1987 Mar; 5(2):122-33. PubMed ID: 3572050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of interleukin-3 (IL-3) on the hematopoietic toxicity associated with combination anti-viral drugs (zidovudine and DDI) in vitro using retrovirus-infected bone marrow cells.
    Gallicchio VS; Hughes NK
    Int J Immunopharmacol; 1994 Apr; 16(4):359-66. PubMed ID: 8045675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
    Chow FP; Zsebo K; Hamburger AW
    Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination interleukin-1 and erythropoietin in ameliorating the hematopoietic toxicity associated with the use of zidovudine administered to normal mice.
    Gallicchio VS; Hughes NK; Tse KF; Gaines H
    Life Sci; 1994; 54(20):PL351-61. PubMed ID: 8190019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors.
    Gallicchio VS; Hughes NK
    Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective modulation of the haematopoietic toxicity associated with zidovudine exposure to murine and human haematopoietic progenitor stem cells in vitro with lithium chloride.
    Gallicchio VS; Hughes NK
    J Intern Med; 1992 Mar; 231(3):219-26. PubMed ID: 1313488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased hematopoietic toxicity following administration of interferon-a with combination dideoxynucleoside therapy (zidovudine plus ddI) administered in normal mice.
    Gallicchio VS; Scott KW; Hughes NK; Tse KF; Gaines H; Kirk PR; Birch NJ
    Life Sci; 1995; 56(3):PL71-81. PubMed ID: 7823768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
    Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
    Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to establish long-term marrow cultures from immunodeficient mice (MAIDS): effect of zidovudine in vitro.
    Tse KF; Hughes NK; Gallicchio VS
    J Leukoc Biol; 1993 Jun; 53(6):658-65. PubMed ID: 8315348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice.
    Gallicchio VS; Hughes NK; Tse KF; Gaines H
    Growth Factors; 1993; 9(3):177-83. PubMed ID: 8274295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained elevation of platelet counts by long-term azidothymidine treatment of immunosuppressed mice.
    Chow FP; Chen RB; Hamburger AW
    J Lab Clin Med; 1993 Apr; 121(4):562-9. PubMed ID: 8454938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an insulin-like growth factor-interleukin-3 fusion protein in reversing the hematopoietic toxicity associated with azidothymidine in mice.
    Difalco MR; Dufresne L; Congote LF
    J Pharmacol Exp Ther; 1998 Feb; 284(2):449-54. PubMed ID: 9454783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
    Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained zidovudine treatment on hematopoiesis in immunodeficient mice.
    Gallicchio VS; Hughes NK; Tse KF
    Int J Immunopharmacol; 1993 Aug; 15(6):673-81. PubMed ID: 8407052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.